Arlene M. Badillo
FDA investigator
Appears on 1 document from 2001, mostly at sites in Puerto Rico. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 18.0
- Observations per 483
- 2001
- First seen
- 2001
- Most recent
What they cite most
From 18 observations- 21 CFR 211.100Written procedures; deviations6
- 21 CFR 211.192Production record review5
- 21 CFR 211.160General requirements2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.180General requirements1
- 21 CFR 211.194Laboratory records1
Activity by year
2001: 1
Where
Puerto Rico 1
Often inspects with
Is Arlene M. Badillo coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2001-06-05 | 483 Schering-Plough Products, LLCJun 5, 2001 · Las Piedras, Puerto Rico | Las Piedras, Puerto Rico | 18 |
About this profile
What does Arlene M. Badillo inspect?
Arlene M. Badillo appears on 1 document on file covering 1 site, mostly in Puerto Rico.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Arlene M. Badillo is dated Jun 5, 2001.